Retail pharmacies still dominate diabetes care — you walk in, show a prescription, get your metformin or insulin. But online pharmacies (Netmeds, PharmEasy, 1mg) are the fastest‑growing channel. The India diabetes market forecast predicts that online will capture 25% of the market by 2035, up from 10% today. Why? Convenience, privacy, and price — online discounts can be 20‑30% lower than retail.

What's driving the shift? Younger diabetics who are comfortable with apps. Also, subscription models — you set up automatic refills for your test strips and meds, so you never run out. The India diabetes market analysis notes that insulin still requires a prescription and cold‑chain delivery, but oral drugs and CGMs are easily shipped.

But there's a downside: counterfeit drugs. Some unverified online sellers have been caught selling fake metformin. That's why you should only buy from licensed, verified platforms (look for the Digital India certification).

The bottom line: online pharmacies are convenient and cheaper, but be vigilant. And don't abandon your local chemist entirely — they're invaluable for emergencies and personal advice.

❓ Frequently Asked Questions — Diabetes Market

What is the current size of the India diabetes market?
$6.86 billion in 2024. Full report: India diabetes market report.
Which type of diabetes dominates?
Type 2 diabetes with over 90% share. See the India diabetes market analysis.
Fastest‑growing treatment segment?
Continuous glucose monitoring (CGM). Check India diabetes market trends.
What is the projected market size by 2035?
$13.77 billion. Forecast in India diabetes market forecast.
Who are the key players in India?
Novo Nordisk, Sanofi, Abbott, Eli Lilly. The India diabetes market research has full competitive landscape.